| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 64 | 2024 | 1009 | 5.820 |
Why?
|
| Fetal Growth Retardation | 31 | 2022 | 254 | 4.720 |
Why?
|
| Middle Cerebral Artery | 19 | 2019 | 115 | 3.940 |
Why?
|
| Blood Flow Velocity | 55 | 2021 | 440 | 3.670 |
Why?
|
| Ultrasonography, Doppler | 34 | 2022 | 186 | 3.510 |
Why?
|
| Anemia | 23 | 2018 | 350 | 3.020 |
Why?
|
| Fetal Diseases | 25 | 2018 | 461 | 2.920 |
Why?
|
| Pregnancy | 120 | 2024 | 7536 | 2.330 |
Why?
|
| Gestational Age | 41 | 2024 | 1227 | 2.190 |
Why?
|
| Fetus | 35 | 2018 | 590 | 2.120 |
Why?
|
| Pregnancy Outcome | 17 | 2024 | 634 | 1.990 |
Why?
|
| Cerebral Arteries | 16 | 2017 | 83 | 1.640 |
Why?
|
| Pregnancy Complications | 10 | 2020 | 550 | 1.590 |
Why?
|
| Umbilical Arteries | 18 | 2022 | 98 | 1.520 |
Why?
|
| Rh Isoimmunization | 13 | 2011 | 28 | 1.450 |
Why?
|
| Cesarean Section | 7 | 2024 | 407 | 1.400 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2020 | 62 | 1.370 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 9 | 2008 | 21 | 1.260 |
Why?
|
| Fetal Weight | 5 | 2022 | 72 | 1.160 |
Why?
|
| Blood Transfusion, Intrauterine | 10 | 2010 | 37 | 1.150 |
Why?
|
| Fetal Blood | 8 | 2020 | 172 | 1.150 |
Why?
|
| Erythroblastosis, Fetal | 9 | 2005 | 27 | 1.090 |
Why?
|
| Pre-Eclampsia | 5 | 2024 | 230 | 1.030 |
Why?
|
| Umbilical Veins | 6 | 2008 | 68 | 1.010 |
Why?
|
| Umbilical Cord | 3 | 2021 | 59 | 0.930 |
Why?
|
| Female | 124 | 2024 | 70699 | 0.900 |
Why?
|
| Fetal Viability | 1 | 2024 | 30 | 0.850 |
Why?
|
| Placenta | 10 | 2022 | 539 | 0.810 |
Why?
|
| Delivery, Obstetric | 3 | 2024 | 260 | 0.790 |
Why?
|
| Infant, Newborn | 33 | 2024 | 8540 | 0.760 |
Why?
|
| Fetal Heart | 2 | 2017 | 135 | 0.760 |
Why?
|
| Uterine Artery | 3 | 2019 | 29 | 0.750 |
Why?
|
| Papio | 8 | 2018 | 60 | 0.750 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2020 | 75 | 0.730 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2024 | 78 | 0.690 |
Why?
|
| Pulsatile Flow | 15 | 2018 | 124 | 0.670 |
Why?
|
| Postpartum Period | 2 | 2024 | 231 | 0.660 |
Why?
|
| Humans | 123 | 2024 | 132081 | 0.630 |
Why?
|
| Ethanol | 2 | 2017 | 162 | 0.620 |
Why?
|
| Pulmonary Artery | 3 | 2018 | 463 | 0.590 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 2 | 2017 | 10 | 0.590 |
Why?
|
| Fetal Therapies | 2 | 2018 | 82 | 0.580 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 180 | 0.570 |
Why?
|
| Prospective Studies | 18 | 2024 | 6557 | 0.560 |
Why?
|
| Blood Pressure | 4 | 2024 | 1402 | 0.550 |
Why?
|
| Models, Theoretical | 2 | 2018 | 388 | 0.550 |
Why?
|
| Salpingectomy | 1 | 2017 | 15 | 0.530 |
Why?
|
| Antihypertensive Agents | 3 | 2024 | 430 | 0.520 |
Why?
|
| Fetal Development | 2 | 2017 | 131 | 0.520 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 224 | 0.510 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2024 | 106 | 0.510 |
Why?
|
| Lung | 2 | 2014 | 1556 | 0.500 |
Why?
|
| Fetal Hemoglobin | 3 | 2007 | 28 | 0.490 |
Why?
|
| Blood Glucose | 2 | 2020 | 1121 | 0.490 |
Why?
|
| Fetofetal Transfusion | 5 | 2008 | 195 | 0.480 |
Why?
|
| Ultrasonography, Doppler, Color | 9 | 2013 | 57 | 0.480 |
Why?
|
| Adult | 37 | 2024 | 31558 | 0.470 |
Why?
|
| Hypertension | 4 | 2024 | 1397 | 0.470 |
Why?
|
| Systole | 9 | 2005 | 205 | 0.450 |
Why?
|
| Fetal Organ Maturity | 1 | 2014 | 13 | 0.440 |
Why?
|
| Insulin Resistance | 1 | 2020 | 698 | 0.440 |
Why?
|
| Placental Insufficiency | 3 | 2008 | 15 | 0.410 |
Why?
|
| Premature Birth | 2 | 2008 | 418 | 0.400 |
Why?
|
| Eclampsia | 1 | 2013 | 29 | 0.400 |
Why?
|
| Obesity | 4 | 2018 | 2398 | 0.390 |
Why?
|
| Amniotic Fluid | 6 | 2022 | 154 | 0.390 |
Why?
|
| Risk Assessment | 4 | 2020 | 3727 | 0.390 |
Why?
|
| Hysterotomy | 1 | 2013 | 127 | 0.390 |
Why?
|
| Infant, Small for Gestational Age | 6 | 2024 | 60 | 0.390 |
Why?
|
| Blood Loss, Surgical | 1 | 2013 | 159 | 0.390 |
Why?
|
| Young Adult | 10 | 2024 | 9938 | 0.390 |
Why?
|
| Urogenital System | 1 | 2011 | 35 | 0.360 |
Why?
|
| Uterus | 5 | 2018 | 547 | 0.360 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 271 | 0.350 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 211 | 0.340 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 2312 | 0.340 |
Why?
|
| Laser-Doppler Flowmetry | 3 | 2000 | 62 | 0.340 |
Why?
|
| Image Enhancement | 1 | 2011 | 173 | 0.340 |
Why?
|
| Polyhydramnios | 6 | 1993 | 56 | 0.330 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2014 | 426 | 0.330 |
Why?
|
| Obstetric Labor, Premature | 6 | 1996 | 84 | 0.320 |
Why?
|
| Monkey Diseases | 3 | 2016 | 18 | 0.320 |
Why?
|
| Indomethacin | 7 | 1991 | 82 | 0.320 |
Why?
|
| Perinatology | 1 | 2010 | 35 | 0.320 |
Why?
|
| Fetal Monitoring | 4 | 2024 | 58 | 0.320 |
Why?
|
| Urogenital Abnormalities | 1 | 2011 | 167 | 0.310 |
Why?
|
| Fetoscopy | 1 | 2014 | 448 | 0.310 |
Why?
|
| Parvoviridae Infections | 2 | 2007 | 37 | 0.310 |
Why?
|
| Cardiotocography | 2 | 2007 | 20 | 0.310 |
Why?
|
| Infant Mortality | 2 | 2007 | 178 | 0.300 |
Why?
|
| Nifedipine | 2 | 2024 | 22 | 0.300 |
Why?
|
| Infant, Premature | 3 | 2007 | 843 | 0.300 |
Why?
|
| Ultrasonography | 16 | 2022 | 988 | 0.290 |
Why?
|
| Amniocentesis | 6 | 2005 | 77 | 0.280 |
Why?
|
| Sensitivity and Specificity | 12 | 2018 | 2138 | 0.280 |
Why?
|
| Vena Cava, Inferior | 2 | 2008 | 105 | 0.280 |
Why?
|
| Renal Artery | 5 | 2002 | 69 | 0.280 |
Why?
|
| Splenic Artery | 4 | 2002 | 22 | 0.270 |
Why?
|
| Cerebrovascular Circulation | 4 | 2007 | 476 | 0.270 |
Why?
|
| Ductus Arteriosus | 6 | 1996 | 62 | 0.260 |
Why?
|
| Antigens, CD34 | 1 | 2006 | 109 | 0.250 |
Why?
|
| ABO Blood-Group System | 1 | 2006 | 66 | 0.250 |
Why?
|
| Reference Values | 9 | 2011 | 703 | 0.250 |
Why?
|
| Mesenteric Artery, Superior | 4 | 2001 | 33 | 0.250 |
Why?
|
| Cordocentesis | 6 | 2007 | 10 | 0.250 |
Why?
|
| Receptors, Cannabinoid | 2 | 2017 | 10 | 0.240 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2020 | 124 | 0.230 |
Why?
|
| Pulse | 5 | 1992 | 27 | 0.230 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 233 | 0.220 |
Why?
|
| ROC Curve | 9 | 2018 | 600 | 0.220 |
Why?
|
| Abdomen | 2 | 1995 | 135 | 0.220 |
Why?
|
| Operative Time | 2 | 2017 | 190 | 0.220 |
Why?
|
| Labetalol | 1 | 2024 | 11 | 0.220 |
Why?
|
| Prognosis | 7 | 2020 | 5013 | 0.200 |
Why?
|
| Infant, Extremely Premature | 1 | 2024 | 108 | 0.200 |
Why?
|
| Fetal Death | 7 | 2012 | 119 | 0.200 |
Why?
|
| Cervical Ripening | 1 | 2002 | 7 | 0.190 |
Why?
|
| Abruptio Placentae | 2 | 2013 | 16 | 0.190 |
Why?
|
| Misoprostol | 1 | 2002 | 27 | 0.190 |
Why?
|
| Blood Circulation | 3 | 1991 | 17 | 0.190 |
Why?
|
| Oxytocics | 1 | 2002 | 28 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2006 | 551 | 0.190 |
Why?
|
| Embryonic and Fetal Development | 3 | 1997 | 129 | 0.190 |
Why?
|
| Time Factors | 5 | 2024 | 6443 | 0.190 |
Why?
|
| Regional Blood Flow | 4 | 2008 | 212 | 0.180 |
Why?
|
| Oxytocin | 1 | 2002 | 74 | 0.180 |
Why?
|
| Placental Circulation | 3 | 2013 | 25 | 0.180 |
Why?
|
| Pulmonary Circulation | 1 | 2002 | 117 | 0.170 |
Why?
|
| Pregnancy Complications, Hematologic | 2 | 2000 | 29 | 0.170 |
Why?
|
| Constriction | 1 | 2021 | 47 | 0.170 |
Why?
|
| Pregnancy, High-Risk | 3 | 2011 | 43 | 0.170 |
Why?
|
| Drainage | 3 | 2013 | 262 | 0.170 |
Why?
|
| Oligohydramnios | 3 | 2002 | 48 | 0.170 |
Why?
|
| Risk Factors | 8 | 2020 | 10936 | 0.160 |
Why?
|
| Placenta Diseases | 1 | 2000 | 61 | 0.160 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2000 | 66 | 0.160 |
Why?
|
| Diseases in Twins | 1 | 2000 | 97 | 0.160 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2017 | 27 | 0.160 |
Why?
|
| Hemangioma | 1 | 2000 | 97 | 0.160 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 206 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2006 | 2510 | 0.150 |
Why?
|
| Hematocrit | 3 | 2004 | 111 | 0.150 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 4687 | 0.150 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2014 | 99 | 0.150 |
Why?
|
| Heart Rate, Fetal | 3 | 2000 | 63 | 0.150 |
Why?
|
| Hemorheology | 1 | 1998 | 25 | 0.140 |
Why?
|
| Resuscitation | 1 | 2021 | 268 | 0.140 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2018 | 43 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2019 | 376 | 0.140 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2018 | 83 | 0.140 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2017 | 84 | 0.140 |
Why?
|
| Prenatal Diagnosis | 4 | 2015 | 631 | 0.140 |
Why?
|
| Retrospective Studies | 9 | 2013 | 17367 | 0.140 |
Why?
|
| Parturition | 1 | 2018 | 66 | 0.130 |
Why?
|
| Portal Vein | 1 | 1997 | 88 | 0.130 |
Why?
|
| Endocannabinoids | 2 | 2017 | 44 | 0.130 |
Why?
|
| Sterilization, Tubal | 1 | 2017 | 16 | 0.130 |
Why?
|
| Hemoglobins | 3 | 2005 | 322 | 0.130 |
Why?
|
| Adrenal Glands | 1 | 1996 | 46 | 0.130 |
Why?
|
| Vasodilation | 1 | 2017 | 181 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2005 | 1007 | 0.120 |
Why?
|
| Prenatal Care | 1 | 2018 | 359 | 0.120 |
Why?
|
| Male | 14 | 2020 | 64952 | 0.120 |
Why?
|
| Anemia, Hemolytic | 1 | 1995 | 32 | 0.120 |
Why?
|
| Cerebral Hemorrhage | 1 | 1996 | 158 | 0.120 |
Why?
|
| Proteinuria | 1 | 2015 | 111 | 0.120 |
Why?
|
| Cerebellum | 2 | 1996 | 464 | 0.120 |
Why?
|
| Insulin | 1 | 2020 | 1168 | 0.110 |
Why?
|
| Heart Failure | 1 | 2008 | 2398 | 0.110 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 356 | 0.110 |
Why?
|
| Observer Variation | 3 | 2005 | 305 | 0.110 |
Why?
|
| Gluconeogenesis | 1 | 2015 | 96 | 0.110 |
Why?
|
| Lactic Acid | 1 | 2015 | 154 | 0.110 |
Why?
|
| Animals | 10 | 2018 | 34845 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 3015 | 0.110 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2013 | 2 | 0.100 |
Why?
|
| Arteries | 4 | 1996 | 221 | 0.100 |
Why?
|
| Tennessee | 1 | 2013 | 35 | 0.100 |
Why?
|
| Macaca fascicularis | 1 | 2013 | 88 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 462 | 0.100 |
Why?
|
| Incidence | 2 | 2013 | 3370 | 0.100 |
Why?
|
| Pregnancy, Multiple | 1 | 1992 | 48 | 0.100 |
Why?
|
| Trachea | 1 | 2014 | 210 | 0.090 |
Why?
|
| Models, Animal | 1 | 2014 | 469 | 0.090 |
Why?
|
| Algorithms | 3 | 2015 | 1725 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2013 | 5169 | 0.090 |
Why?
|
| Isoantibodies | 2 | 2002 | 58 | 0.090 |
Why?
|
| Regression Analysis | 2 | 2007 | 796 | 0.090 |
Why?
|
| Pelvis | 1 | 1991 | 73 | 0.090 |
Why?
|
| Blood Coagulation Factors | 1 | 1991 | 35 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2007 | 1571 | 0.080 |
Why?
|
| Leg | 1 | 1991 | 134 | 0.080 |
Why?
|
| Erythrocytes | 2 | 2002 | 201 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2024 | 13015 | 0.080 |
Why?
|
| False Positive Reactions | 2 | 2000 | 142 | 0.080 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 1990 | 28 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2024 | 1227 | 0.080 |
Why?
|
| Twins | 3 | 1995 | 72 | 0.080 |
Why?
|
| Morbidity | 2 | 2001 | 253 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2016 | 916 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 1989 | 104 | 0.080 |
Why?
|
| Heart Neoplasms | 1 | 2010 | 105 | 0.070 |
Why?
|
| Teratoma | 1 | 2010 | 129 | 0.070 |
Why?
|
| Infant | 2 | 2022 | 13037 | 0.070 |
Why?
|
| Amnion | 2 | 2001 | 40 | 0.070 |
Why?
|
| Biophysical Phenomena | 1 | 2008 | 39 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2002 | 1500 | 0.070 |
Why?
|
| Biophysics | 1 | 2008 | 47 | 0.070 |
Why?
|
| Blood Gas Analysis | 1 | 2008 | 85 | 0.070 |
Why?
|
| Acid-Base Equilibrium | 1 | 2008 | 60 | 0.070 |
Why?
|
| Heart Valves | 1 | 2008 | 52 | 0.070 |
Why?
|
| Survival Rate | 2 | 2007 | 2192 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2010 | 208 | 0.070 |
Why?
|
| Retreatment | 2 | 2005 | 93 | 0.070 |
Why?
|
| Oxygen | 1 | 2011 | 569 | 0.070 |
Why?
|
| Ultrasonics | 4 | 1999 | 36 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2013 | 1700 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2018 | 3753 | 0.070 |
Why?
|
| Liver | 2 | 2004 | 1797 | 0.070 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 41 | 0.070 |
Why?
|
| Birth Weight | 2 | 1999 | 351 | 0.060 |
Why?
|
| Platelet Count | 1 | 2007 | 139 | 0.060 |
Why?
|
| Hematoma | 2 | 2012 | 92 | 0.060 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2017 | 6 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2018 | 3414 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 287 | 0.060 |
Why?
|
| Probability | 1 | 2005 | 322 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 294 | 0.060 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2002 | 170 | 0.060 |
Why?
|
| United States | 1 | 2020 | 11652 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2006 | 224 | 0.060 |
Why?
|
| Congenital Abnormalities | 2 | 2006 | 299 | 0.050 |
Why?
|
| Adolescent | 4 | 2019 | 20530 | 0.050 |
Why?
|
| Steroids | 1 | 2004 | 174 | 0.050 |
Why?
|
| Exercise Test | 1 | 2004 | 256 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2006 | 381 | 0.050 |
Why?
|
| Arterial Pressure | 1 | 2024 | 127 | 0.050 |
Why?
|
| Homeostasis | 1 | 2007 | 722 | 0.050 |
Why?
|
| Kidney | 1 | 1990 | 1338 | 0.050 |
Why?
|
| Pregnancy, Prolonged | 1 | 2002 | 3 | 0.050 |
Why?
|
| Parvovirus B19, Human | 1 | 2002 | 31 | 0.050 |
Why?
|
| Administration, Intravaginal | 1 | 2002 | 9 | 0.050 |
Why?
|
| HELLP Syndrome | 1 | 2002 | 17 | 0.050 |
Why?
|
| Hydatidiform Mole | 1 | 2002 | 20 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2002 | 40 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 247 | 0.050 |
Why?
|
| Brain | 1 | 1994 | 3194 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 699 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2002 | 590 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 2002 | 111 | 0.040 |
Why?
|
| Medical Records | 1 | 2002 | 189 | 0.040 |
Why?
|
| Logistic Models | 3 | 2002 | 1836 | 0.040 |
Why?
|
| International Cooperation | 1 | 2001 | 165 | 0.040 |
Why?
|
| Encephalomalacia | 1 | 2000 | 4 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3045 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2000 | 25 | 0.040 |
Why?
|
| Blood Group Incompatibility | 1 | 2000 | 27 | 0.040 |
Why?
|
| Middle Aged | 1 | 2019 | 28980 | 0.040 |
Why?
|
| Carotid Artery, Internal | 2 | 1990 | 58 | 0.040 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 1998 | 3 | 0.040 |
Why?
|
| Cerebral Palsy | 1 | 2000 | 85 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1670 | 0.040 |
Why?
|
| Splenomegaly | 1 | 1998 | 32 | 0.040 |
Why?
|
| Obstetrics | 1 | 2021 | 240 | 0.040 |
Why?
|
| Hydrops Fetalis | 3 | 2002 | 85 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2002 | 1653 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2018 | 193 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1998 | 131 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2002 | 496 | 0.030 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1998 | 93 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 2018 | 97 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 1997 | 28 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2021 | 778 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 1249 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 488 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 5407 | 0.030 |
Why?
|
| Rheology | 2 | 1999 | 32 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 1995 | 47 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 1995 | 39 | 0.030 |
Why?
|
| Veins | 1 | 1995 | 101 | 0.030 |
Why?
|
| Fetal Hypoxia | 1 | 1995 | 14 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 1966 | 0.030 |
Why?
|
| Perfusion | 1 | 2015 | 208 | 0.030 |
Why?
|
| Blood Group Antigens | 1 | 1995 | 77 | 0.030 |
Why?
|
| Registries | 1 | 2001 | 1591 | 0.030 |
Why?
|
| Vertebral Artery | 1 | 1994 | 22 | 0.030 |
Why?
|
| Linear Models | 1 | 1996 | 711 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2087 | 0.030 |
Why?
|
| Glycerides | 1 | 2013 | 16 | 0.030 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2013 | 25 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2013 | 29 | 0.030 |
Why?
|
| Arachidonic Acids | 1 | 2013 | 29 | 0.030 |
Why?
|
| Pregnancy Trimesters | 1 | 2013 | 34 | 0.020 |
Why?
|
| Testosterone | 1 | 2018 | 611 | 0.020 |
Why?
|
| Intestines | 1 | 1997 | 606 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 348 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 1990 | 65 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1224 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 351 | 0.020 |
Why?
|
| Stillbirth | 1 | 2013 | 103 | 0.020 |
Why?
|
| Animals, Laboratory | 1 | 2012 | 12 | 0.020 |
Why?
|
| Leptin | 1 | 2013 | 219 | 0.020 |
Why?
|
| Uterine Hemorrhage | 1 | 2012 | 43 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 65 | 0.020 |
Why?
|
| Placentation | 1 | 2012 | 60 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2011 | 39 | 0.020 |
Why?
|
| Myocardium | 1 | 2016 | 907 | 0.020 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 1991 | 7 | 0.020 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1991 | 33 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 286 | 0.020 |
Why?
|
| Craniofacial Dysostosis | 1 | 1991 | 19 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 1992 | 183 | 0.020 |
Why?
|
| Chorioamnionitis | 1 | 1991 | 45 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 801 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 304 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 1990 | 37 | 0.020 |
Why?
|
| Hemangioma, Cavernous | 1 | 1990 | 20 | 0.020 |
Why?
|
| Pericardiocentesis | 1 | 2010 | 17 | 0.020 |
Why?
|
| Betamethasone | 1 | 1989 | 14 | 0.020 |
Why?
|
| Renal Circulation | 1 | 1990 | 47 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1992 | 605 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1352 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 1990 | 104 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1018 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2000 | 1866 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1989 | 254 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2012 | 517 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1991 | 323 | 0.020 |
Why?
|
| Body Weight | 1 | 1992 | 995 | 0.020 |
Why?
|
| Vascular Resistance | 2 | 1999 | 195 | 0.020 |
Why?
|
| Glucose | 1 | 1991 | 871 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 3404 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1989 | 861 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 2662 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1991 | 982 | 0.010 |
Why?
|
| Texas | 1 | 2012 | 3632 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2004 | 206 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 821 | 0.010 |
Why?
|
| Spleen | 1 | 1998 | 271 | 0.010 |
Why?
|
| Comorbidity | 1 | 2002 | 1610 | 0.010 |
Why?
|
| Trisomy | 1 | 1995 | 112 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 3086 | 0.010 |
Why?
|
| Urination | 1 | 1991 | 27 | 0.010 |
Why?
|
| Blood Viscosity | 1 | 1990 | 11 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1990 | 69 | 0.010 |
Why?
|
| Diuresis | 1 | 1990 | 46 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1990 | 166 | 0.010 |
Why?
|
| Diastole | 1 | 1989 | 181 | 0.000 |
Why?
|
| Syndrome | 1 | 1991 | 1174 | 0.000 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 1990 | 211 | 0.000 |
Why?
|
| Hypertension, Pulmonary | 1 | 1990 | 463 | 0.000 |
Why?
|
| Echocardiography | 1 | 1990 | 1126 | 0.000 |
Why?
|